Coronary artery stents: Part I. Evolution of percutaneous coronary intervention.

  title={Coronary artery stents: Part I. Evolution of percutaneous coronary intervention.},
  author={Lisa T Newsome and Michael A. Kutcher and Roger L. Royster},
  journal={Anesthesia and analgesia},
  volume={107 2},
The subspecialty of interventional cardiology has made significant progress in the management of coronary artery disease over the past three decades with the development of percutaneous coronary transluminal angioplasty, atherectomy, and bare-metal and drug-eluting stents (DES). Bare-metal stents (BMS) maintain vessel lumen diameter by acting as a scaffold and prevent collapse incurred by angioplasty. However, these devices cause neointimal hyperplasia leading to in-stent restenosis and… CONTINUE READING
Related Discussions
This paper has been referenced on Twitter 1 time. VIEW TWEETS


Publications citing this paper.
Showing 1-10 of 26 extracted citations


Publications referenced by this paper.
Showing 1-10 of 179 references

Duration of clopidogrel therapy with drug-eluting stents.

The New England journal of medicine • 2010
View 4 Excerpts
Highly Influenced

The development of interventional cardiology

King SB
J Am Coll Cardiol 1998;31(4 suppl B):64B–88B • 1998
View 10 Excerpts
Highly Influenced

The M-Heart Investigators. Restenosis after coronary angioplasty: a multivariate statistical model to relate lesion and procedure variables to restenosis

JW JrHirshfeld, JS Schwartz, +11 authors CJ Pepine
View 4 Excerpts
Highly Influenced

Bare metal stent restenosis is not a benign clinical entity.

American heart journal • 2006
View 3 Excerpts
Highly Influenced

Fourth annual American College of Cardiology international lecture: a journey in the interventional field.

Journal of the American College of Cardiology • 2006
View 7 Excerpts
Highly Influenced

Similar Papers

Loading similar papers…